Pilot Trial Comparing Two Different Wavelengths of Light (Blue Versus Red) During Levulan(TM)-Based Photodynamic Therapy of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Trial Profile

Pilot Trial Comparing Two Different Wavelengths of Light (Blue Versus Red) During Levulan(TM)-Based Photodynamic Therapy of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Aminolevulinic acid (Primary)
  • Indications Basal cell nevus syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 May 2017 Status changed from active, no longer recruiting to completed.
    • 01 Aug 2016 Status changed from not yet recruiting to active, no longer recruiting.
    • 18 Aug 2015 Planned initiation date changed from 1 Apr 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top